1 of 12

Slide Notes

DownloadGo Live

LSD and ECSTASY

No Description

PRESENTATION OUTLINE

LSD AND ECSTASY

WHO WANTS TO HALLUCINATE?

DESCRIPTION

LSD
lysergic acid diethylamide, aka Acid, is a hallucinogen

PLEASURABLE EFFECTS

LSD
hallucinations including hearing sounds, seeing images, and feeling sensations

NEGATIVE EFFECTS

LSD
dilated pupils, rise in body temperature, increase in blood pressure, increase or decrease of heart rate, loss of appetite, sleeplessness, dry mouth, tremors, severe, terrifying thoughts and feelings, fear of losing control, fear of insanity and death, and despair

WHAT HAPPENS TO THE BODY?

LSD
turns off the brain regions for constraining consciousness, the overactive imagination is caused by the serotonin receptors.

3 FACTS

LSD
1. Created on accident
2. Originally developed as a respiratory and circulatory stimulant
3. Can cause a disorder that causes permanent damage

BRIEF HISTORY

LSD
Used in the mid fifties to treat psychological and substance abuse patients. Said to have a 50% cure rate of alcoholism

DESCRIPTION

ECSTASY
It is chemically similar to both stimulants and hallucinogens, producing feelings of increased energy, pleasure, emotional warmth, and distorted sensory and time perception.

PLEASURABLE EFFECTS

ECSTASY
intense feeling of excitement, increased energy, enhanced mood and increased sociability.

NEGATIVE EFFECTS

ECSTASY
negative effect : if you take it more than once or twice or at all if you have an addictive personality.

3 FACTS

ECSTASY
body effect: increased confidence and energy
lowered inhibitions
feelings of wellbeing
feelings of closeness to others
empathy
anxiety
paranoia, aggression and psychosis
poor muscle control and unsteadiness
muscle aches and stiffness
increased blood pressure & heart rate
nausea
loss of appetite
increased body temperature
sweating
skin tingles
dilated pupils
heightened sensations (sight, hearing, touch)
jaw clenching
teeth grinding.

BRIEF HISTORY

ECSTASY
brief history: MDMA was developed by a German pharmaceutical company in 1912. Originally known as “Methylsafrylaminc,” it was intended as a parent compound to synthesize medications that control bleeding, not to control appetite as is often incorrectly cited